跳至主要内容
临床试验/NCT07614698
NCT07614698招募中不适用

Evaluation of the Efficacy of a Topical Formulation Containing Acetyl Hexapeptide-37 on Skin Barrier Recovery of the Forearm After Controlled Damage Using the Tape-stripping Method

University of Split, School of Medicine1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年6月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1

研究概览

简要总结

The goal of this clinical trial is to evaluate the efficacy of a topical peptide-based formulation containing Acetyl Hexapeptide-37 in promoting skin barrier recovery after controlled disruption in healthy adult participants.

The main questions it aims to answer are:

  • Does the peptide cream speed up the recovery of the skin barrier after it has been slightly damaged with tape-stripping method?
  • How does the peptide cream compare to a placebo (a cream with no active ingredient) in improving skin hydration and reducing redness?

Researchers will compare the peptide cream to a placebo to assess its effects on skin barrier recovery

Participants will:

  • Undergo controlled disruption of the skin barrier on the volar forearm using the tape-stripping method.
  • One forearm will receive the peptide-based cream containing Acetyl Hexapeptide-37, while the other (contralateral) forearm will receive a placebo formulation.
  • Attend scheduled visits for non-invasive assessments of skin barrier function, including transepidermal water loss, skin hydration, and erythema

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy volunteers who gave written informed consent

排除标准

  • skin disease
  • skin damage on measurement sites
  • use of corticosteroids, antihistamines and immunomodulators a month prior the inclusion and during the trial
  • use of emollients three days prior the inclusion in the trial
  • non-adherence to the trial protocol
  • exposure to artificial and excessive natural ultraviolet (UV) radiation
  • pregnancy or breastfeeding
  • immunosuppression
  • allergic or irritant reactions to the constituents of the cream

研究组 & 干预措施

Placebo treatment

Placebo Comparator

The other forearm will be treated with a placebo ointment. The allocation of the treatment (left or right forearm) will be determined according to the randomization protocol.

干预措施: Placebo (Other)

Active treatment

Experimental

One forearm will be treated with the peptide-based cream containing Acetyl Hexapeptide-37. The treated forearm (left or right) will be assigned according to the randomization protocol.

干预措施: Acetyl Hexapeptide-37 (Other)

Untreated Control Site

No Intervention

A designated skin site on either forearm will undergo tape-stripping to induce skin barrier disruption but will not receive any topical treatment. This site will serve as a control for natural skin barrier recovery.

研究者

发起方
University of Split, School of Medicine
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验